Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 5Breast 3Lymphoid 2Dermatologic 2Sarcoma 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Follicular 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Testicular Neoplasms 1Sarcoma 1Prostatic Neoplasms 1Oligodendroglioma 1Melanoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Kidney Neoplasms 1Glioma 1Carcinoma, Merkel Cell 1Carcinoma 1Astrocytoma 1

Interventions

pembrolizumab 7Nivolumab 3poly ICLC 2durvalumab 2Rituximab 2Gemcitabine 2Capecitabine 2utomilumab 1tremelimumab 1tanespimycin 1mirabegron 1entinostat 1ciforadenant 1cemiplimab 1Vorinostat 1Thalidomide 1Specimen Handling 1SUB1 protein, human 1SRA737 1Ritonavir 1Radiotherapy 1Radiation 1Polymerase Chain Reaction 1Paclitaxel 1Nicotine 1Microarray Analysis 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Injections, Subcutaneous 1Indinavir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × poly ICLC × Lymphoid × Clear all
NCT03789097 2026-05-22

Vaccination With Flt3L, Radiation, and Poly-ICLC

Icahn School of Medicine at Mount Sinai

Phase 1/2 Completed
17 enrolled
BreastHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT02643303 2022-12-02

A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Ludwig Institute for Cancer Research

Phase 1/2 Completed
58 enrolled 24 charts
BreastDermatologicGenitourinaryHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Kidney Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡